Technology areas: Biotechnology & Pharmaceuticals • Medical Devices & Mechanical Engineering
21 pending office actions • 16 art units • 19 examiners • 0 of 21 (0%) have an AI response strategy ready • 21 patents granted in the last 365 days
University of Miami has 21 pending office actions in Biotechnology & Pharmaceuticals. The portfolio involves 19 distinct examiners and 16 distinct art units, indicating a broad and distributed prosecution workload. Because the pending-action figure exceeds both the examiner and art-unit figures, some examination resources handle more than one matter, while the matters remain spread across numerous units.
JANG, CHRISTIAN Y is the busiest examiner, with 2 pending matters. That examiner handles only a portion of the pending portfolio, so a centralized issue-tracking process can help identify recurring claim or disclosure concerns without replacing matter-specific analysis. Responses should account for the different examiner and art-unit settings represented in the portfolio.
Based on the USPTO statutory response window for each pending office action. 7 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 7 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 6 (29%) |
| §103 only | 2 (10%) |
| Double-patenting only | 1 (5%) |
| Double-patenting + other | 1 (5%) |
| Multi-statute (no §101) | 10 (48%) |
| No statute on record | 1 (5%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| JANG, CHRISTIAN Y | 2 | 68.7% | +21.0% |
| HOLTZMAN, KATHERINE ANN | 2 | 64.8% | +59.4% |
| DUONG, JOHNNYKHOI BAO | 1 | 63.5% | +33.3% |
| PRAGANI, RAJAN | 1 | 52.4% | +71.4% |
| HASAN, MOHAMMED A | 1 | 90.3% | +5.1% |
| POHNERT, STEVEN C | 1 | 12.5% | +18.2% |
| KALIHER, HANS CHRISTIAN | 1 | 62.9% | +27.3% |
| LEE, ANDREW P | 1 | 48.5% | +22.8% |
| LUAN, SCOTT | 1 | 65.6% | +12.2% |
| SPENCE, JENNIFER SUZANNE | 1 | 66.9% | +46.0% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18628644 | ROBOTIC SYSTEMS, DEVICES, AND METHODS FOR VASCULAR ACCESS | LUAN, SCOTT | 30d overdue |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | HOLTZMAN, KATHERINE ANN | 19d overdue |
| 17639510 | QUANTIFICATION OF SYMMETRY AND REPEATABILITY IN LIMB MOTION FOR TREATMENT OF ABNORMAL MOTION PATTERNS | LOPEZ, SEVERO ANTON P | 9d overdue |
| 17915971 | PHOTODYNAMIC ANTIMICROBIAL THERAPY DEVICE | SCHMITT, BENJAMIN ALLYN | 27d |
| 18556593 | ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES | RIGA, MICHAEL ANGELO | 69d |
| 17785524 | Methods for Identifying Modulators of G Protein-Coupled Receptors | GRASER, JENNIFER E | 72d |
| 18867355 | METHOD AND SYSTEM TO MEASURE OBJECTIVE VISUAL PHOTOSENSITIVITY DISCOMFORT THRESHOLD | DUONG, JOHNNYKHOI BAO | — |
| 18745908 | Method and System of Augmenting Cancer Therapy | POHNERT, STEVEN C | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18628644 | ROBOTIC SYSTEMS, DEVICES, AND METHODS FOR VASCULAR ACCESS | LUAN, SCOTT | 30d overdue |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | HOLTZMAN, KATHERINE ANN | 19d overdue |
| 18672929 | METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS | LEE, ANDREW P | 39d |
| 18867355 | METHOD AND SYSTEM TO MEASURE OBJECTIVE VISUAL PHOTOSENSITIVITY DISCOMFORT THRESHOLD | DUONG, JOHNNYKHOI BAO | — |
| 18861068 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | PRAGANI, RAJAN | — |
| 18745908 | Method and System of Augmenting Cancer Therapy | POHNERT, STEVEN C | — |
| 18713960 | OCULAR DRUG TRANSFER AND DISPENSING DEVICE | KALIHER, HANS CHRISTIAN | — |
| 18666176 | METHOD AND SYSTEM FOR ADJUSTING AUDIO SIGNALS BASED ON MOTION DEVIATION | JANG, CHRISTIAN Y | — |
| Art Unit | Apps |
|---|---|
| 3791 | 4 |
| 1674 | 2 |
| 1646 | 2 |
| 2667 | 1 |
| 1614 | 1 |
| 2872 | 1 |
| 1683 | 1 |
| 3781 | 1 |
| 1691 | 1 |
| 3792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18867355 | METHOD AND SYSTEM TO MEASURE OBJECTIVE VISUAL PHOTOSENSITIVITY DISCOMFORT THRESHOLD | DUONG, JOHNNYKHOI BAO | 2667 | §103§112 | Non-Final OA | — | Pending | Nov 19, 2024 |
| 18861068 | THERAPEUTIC COMPOSITIONS FOR SKIN DISORDERS AND WOUND REPAIR | PRAGANI, RAJAN | 1614 | §103 | Non-Final OA | — | Pending | Oct 28, 2024 |
| 18924936 | VISION TESTING VIA PREDICTION-BASED SETTING OF INITIAL STIMULI CHARACTERISTICS FOR USER INTERFACE LOCATIONS | HASAN, MOHAMMED A | 2872 | Other | Non-Final OA | — | Pending | Oct 23, 2024 |
| 18745908 | Method and System of Augmenting Cancer Therapy | POHNERT, STEVEN C | 1683 | §101§103§112 | Non-Final OA | — | Pending | Jun 17, 2024 |
| 18713960 | OCULAR DRUG TRANSFER AND DISPENSING DEVICE | KALIHER, HANS CHRISTIAN | 3781 | §102§103 | Non-Final OA | — | Pending | May 28, 2024 |
| 18672929 | METHODS FOR TREATING MUCOPOLYSACCHARIDOSIS | LEE, ANDREW P | 1691 | §103 | Final Rejection | 39d | Pending | May 23, 2024 |
| 18666176 | METHOD AND SYSTEM FOR ADJUSTING AUDIO SIGNALS BASED ON MOTION DEVIATION | JANG, CHRISTIAN Y | 3791 | §101DP | Non-Final OA | — | Pending | May 16, 2024 |
| 18655182 | Contact Lens System and Method for Assessing Intraocular Pressure | JANG, CHRISTIAN Y | 3791 | §101§102§103§112Other | Non-Final OA | — | Pending | May 03, 2024 |
| 18628644 | ROBOTIC SYSTEMS, DEVICES, AND METHODS FOR VASCULAR ACCESS | LUAN, SCOTT | 3792 | §102§103 | Final Rejection | 30d overdue | Pending | Apr 05, 2024 |
| 18418736 | METHOD FOR MANAGING PAIN | SPENCE, JENNIFER SUZANNE | 1633 | §102§103 | Final Rejection | — | Pending | Jan 22, 2024 |
| 18516247 | ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES | HASAN, KHALEDA B | 1636 | DP | Non-Final OA | — | Pending | Nov 21, 2023 |
| 18556593 | ENGINEERED MEGANUCLEASES THAT TARGET HUMAN MITOCHONDRIAL GENOMES | RIGA, MICHAEL ANGELO | 1634 | §103§112Other | Non-Final OA | 69d | Pending | Oct 20, 2023 |
| 18464174 | INFLAMMASOME ANTIBODY COMPOSITON AND METHOD FOR TREATING NEUROLOGIC DISORDER | FONTAINHAS, AURORA M | 1675 | §112DP | Non-Final OA | — | Pending | Sep 08, 2023 |
| 18036494 | MATERIALS AND METHODS FOR TREATING CORNEAL DYSFUNCTION | ABBAS, SYED JARAR | 1674 | §102§103§112 | Final Rejection | — | Pending | May 11, 2023 |
| 18306956 | INNATE IMMUNE PROTEINS AS BIOMARKERS FOR TRAUMATIC BRAIN INJURY IN ADULT AND PEDIATRIC PATIENTS | HOLTZMAN, KATHERINE ANN | 1646 | §101§103§112Other | Final Rejection | 19d overdue | Pending | Apr 25, 2023 |
| 17995548 | A SYSTEM FOR ASSESSING HUMAN MOVEMENT AND BALANCE | HEALY, NOAH MICHAEL | 3791 | §101§112 | Final Rejection | — | Pending | Oct 05, 2022 |
| 17915971 | PHOTODYNAMIC ANTIMICROBIAL THERAPY DEVICE | SCHMITT, BENJAMIN ALLYN | 3796 | §103§112 | Final Rejection | 27d | Pending | Sep 29, 2022 |
| 17822333 | INTERLEUKIN-2/INTERLEUKIN-2 RECEPTOR ALPHA FUSION PROTEINS AND METHODS OF USE | SCHWECHTER, BRANDON ROSS | 1674 | §102§103§112 | Non-Final OA | — | Pending | Aug 25, 2022 |
| 17812058 | METHOD FOR DETECTING INFLAMMASOME PROTEINS AS BIOMARKERS OF NEUROLOGICAL DISORDERS | HOLTZMAN, KATHERINE ANN | 1646 | §103§112Other | Non-Final OA | — | Pending | Jul 12, 2022 |
| 17785524 | Methods for Identifying Modulators of G Protein-Coupled Receptors | GRASER, JENNIFER E | 1645 | §103§112 | Final Rejection | 72d | Pending | Jun 15, 2022 |
| 17639510 | QUANTIFICATION OF SYMMETRY AND REPEATABILITY IN LIMB MOTION FOR TREATMENT OF ABNORMAL MOTION PATTERNS | LOPEZ, SEVERO ANTON P | 3791 | §101§103 | Non-Final OA | 9d overdue | Pending | Mar 01, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUniversity of Miami has 21 pending office actions as of October 2026, spread across 16 art units and 19 examiners.
Christian Y Jang has the most, with 2 of University of Miami's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
